Among patients with pulmonary arterial hypertension treated with 72-week seralutinib, those deemed responders had more improved measures, according to a poster presented at the Pulmonary Vascular ...

PATNA: Bihar’s political climate is heating up ahead of assembly elections, with the main opposition Rashtriya Janata Dal ...

AVEO Oncology, an LG Chem company ("AVEO"), is a biopharmaceutical company that is trying to provide differentiated solutions to improve cancer patients lives, presented two posters during the 2025 ...

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

Radium-223 re-treatment is safe for metastatic castration-resistant prostate cancer, per findings from the 2025 ASCO GU ...

Patient-reported outcomes (PROs) were similar among those treated with tivozanib monotherapy and those given combination ...

Symptom scores remained stable over time, with similar QOL trends in both treatment arms.

Tivozanib plus nivolumab had similar patient-reported outcomes to tivozanib alone in advanced kidney cancer after prior treatment, according to the TiNivo-2 study.

Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, today presented positive, final data from the ...

For media inquiries contact: Sudha Sruthi, Corporate Development email us here ...

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically ...

Highlights include: a poster presentation on machine learning’s ability to investigate the real-world treatment-emergent adverse events that over 5,200 patients experience during 1L treatments for ...